IMAC, Brain Scientific merger to offer range of neurological care
IMAC Holdings and Brain Scientific have agreed to merge to offer solutions that cover the spectrum of care…
Articles by Margarida Maia, PhD
Early NfL blood levels differ in idiopathic and LRRK2 Parkinson’s
People with idiopathic Parkinson’s disease have significantly higher blood levels of neurofilament light chain (NfL) — a biomarker of nerve…
TNFRSF10B protein shows promise as therapeutic target in Parkinson’s
Microglia, the brain’s resident immune cells, may contribute to Parkinson’s disease by releasing tiny vesicles filled with alpha-synuclein —…
Nuplazid, clozapine treat Parkinson’s psychosis without motor decline
Among several atypical antipsychotics, Nuplazid (pimavanserin) seems to be the most effective at easing Parkinson’s disease psychosis (PDP)…
Toxic protein levels higher with REM sleep disorder than Parkinson’s
People with REM sleep behavior disorder (RBD), a sleep disturbance that can precede Parkinson’s disease, have higher levels of toxic…
Microglia may protect neurons in brain during Parkinson’s early stages
Microglia — the brain’s primary immune cells — can help to keep motor symptoms of Parkinson’s disease from quickly…
DBS can ease familial and idiopathic Parkinson’s symptoms equally
Subthalamic deep brain stimulation (DBS) may bring benefits to people with Parkinson’s regardless of whether the disease is…
Community Exercise May Help to Ease Parkinson’s Motor Symptoms
Taking part in a community-based exercise program appears to help relieve the motor symptoms of Parkinson’s disease, a review…
Inflammatory Marker CAR Linked to All-cause Mortality in Parkinson’s
The C-reactive protein-to-albumin ratio (CAR), a measure of inflammation in the body that can be read from a routine blood…
Inflammatory Gut Bacteria, Genes May Be Parkinson’s Biomarkers
Certain pro-inflammatory gut bacteria, genes, and pathways are significantly increased in people with Parkinson’s disease compared with healthy people,…